Characterization of P-Glycoprotein Inhibitors for Evaluating the Effect of P-Glycoprotein on the Intestinal Absorption of Drugs
For developing oral drugs, it is necessary to predict the oral absorption of new chemical entities accurately. However, it is difficult because of the involvement of efflux transporters, including P-glycoprotein (P-gp), in their absorption process. In this study, we conducted a comparative analysis...
Saved in:
Main Authors: | Yusuke Kono (Author), Iichiro Kawahara (Author), Kohei Shinozaki (Author), Ikuo Nomura (Author), Honoka Marutani (Author), Akira Yamamoto (Author), Takuya Fujita (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessment of contribution of BCRP to intestinal absorption of various drugs using portal‐systemic blood concentration difference model in mice
by: Iichiro Kawahara, et al.
Published: (2020) -
Intestinal P-glycoprotein Expression is Multimodally Regulated by Intestinal Ischemia-Reperfusion
by: Yusuke Terada, et al.
Published: (2014) -
Assessment of intestinal permeability of paclitaxel in the presence of NSAIDs and P-glycoprotein inhibitors
by: Zahra Sobhani, et al.
Published: (2017) -
Assessment of intestinal permeability of paclitaxel in the presence of NSAIDs and P-glycoprotein inhibitors
by: Zahra Sobhani, et al.
Published: (2017) -
Overview of P-glycoprotein inhibitors: a rational outlook
by: Kale Mohana Raghava Srivalli, et al.
Published: (2012)